219 related articles for article (PubMed ID: 17849419)
1. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
Spurling CC; Godman CA; Noonan EJ; Rasmussen TP; Rosenberg DW; Giardina C
Mol Carcinog; 2008 Feb; 47(2):137-47. PubMed ID: 17849419
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.
Thangaraju M; Carswell KN; Prasad PD; Ganapathy V
Biochem J; 2009 Jan; 417(1):379-89. PubMed ID: 18789002
[TBL] [Abstract][Full Text] [Related]
3. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
5. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation.
Liu HL; Chen Y; Cui GH; Zhou JF
Acta Pharmacol Sin; 2005 May; 26(5):603-9. PubMed ID: 15842781
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
[TBL] [Abstract][Full Text] [Related]
7. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
8. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells.
Dangond F; Hafler DA; Tong JK; Randall J; Kojima R; Utku N; Gullans SR
Biochem Biophys Res Commun; 1998 Jan; 242(3):648-52. PubMed ID: 9464271
[TBL] [Abstract][Full Text] [Related]
9. Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.
Suzui M; Sunagawa N; Chiba I; Moriwaki H; Yoshimi N
Int J Oncol; 2006 May; 28(5):1193-9. PubMed ID: 16596235
[TBL] [Abstract][Full Text] [Related]
10. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Chen J; Du C; Kang J; Wang J
Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
[TBL] [Abstract][Full Text] [Related]
11. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells.
Zeng L; Xiao Q; Margariti A; Zhang Z; Zampetaki A; Patel S; Capogrossi MC; Hu Y; Xu Q
J Cell Biol; 2006 Sep; 174(7):1059-69. PubMed ID: 16982804
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylase 3 stimulates apoptosis induced by heat shock under acidic conditions in human maxillary cancer.
Narita N; Fujieda S; Tokuriki M; Takahashi N; Tsuzuki H; Ohtsubo T; Matsumoto H
Oncogene; 2005 Nov; 24(49):7346-54. PubMed ID: 16044157
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells.
Lea MA; Ibeh C; Han L; Desbordes C
Anticancer Res; 2010 Feb; 30(2):311-8. PubMed ID: 20332434
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
16. Role for histone deacetylase 1 in human tumor cell proliferation.
Senese S; Zaragoza K; Minardi S; Muradore I; Ronzoni S; Passafaro A; Bernard L; Draetta GF; Alcalay M; Seiser C; Chiocca S
Mol Cell Biol; 2007 Jul; 27(13):4784-95. PubMed ID: 17470557
[TBL] [Abstract][Full Text] [Related]
17. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
19. H3K9 acetylation and radial chromatin positioning.
Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
